Target
Isocitrate dehydrogenase [NADP] cytoplasmic [1-390,401-414,R132C]
Ligand
BDBM317489
Substrate
n/a
IC50
>10000±n/a nM
Citation
 Lin, JEricsson, ACampbell, AGustafson, GWang, ZDiebold, RBAshwell, SLancia, Jr., DRCaravella, JALu, W Fused-bicyclic aryl quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors US Patent  US9624175 Publication Date 4/18/2017 
Target
Name:
Isocitrate dehydrogenase [NADP] cytoplasmic [1-390,401-414,R132C]
Synonyms:
IDH1 | IDHC_HUMAN | Isocitrate dehydrogenase [NADP] cytoplasmic (IDH1)(R132C) | PICD
Type:
Enzyme Catalytic Domain
Mol. Mass.:
45318.79
Organism:
Homo sapiens (Human)
Description:
O75874[1-390,401-414,R132C]
Residue:
404
Sequence:
MSKKISGGSVVEMQGDEMTRIIWELIKEKLIFPYVELDLHSYDLGIENRDATNDQVTKDAAEAIKKHNVGVKCATITPDEKRVEEFKLKQMWKSPNGTIRNILGGTVFREAIICKNIPRLVSGWVKPIIIGCHAYGDQYRATDFVVPGPGKVEITYTPSDGTQKVTYLVHNFEEGGGVAMGMYNQDKSIEDFAHSSFQMALSKGWPLYLSTKNTILKKYDGRFKDIFQEIYDKQYKSQFEAQKIWYEHRLIDDMVAQAMKSEGGFIWACKNYDGDVQSDSVAQGYGSLGMMTSVLVCPDGKTVEAEAAHGTVTRHYRMYQKGQETSTNPIASIFAWTRGLAHRAKLDNNKELAFFANALEEVSIETIEAGFMTKDLAACIKGLPNVQRSDLGENLKIKLAQAKL
  
Inhibitor
Name:
BDBM317489
Synonyms:
6-chloro-3-{[(2-oxo-2H-chromen-6-yl)amino]methyl}-1,2-dihydroquinolin-2-one | US9624175, Compound I-4
Type:
Small organic molecule
Emp. Form.:
C19H13ClN2O3
Mol. Mass.:
352.771
SMILES:
Clc1ccc2[nH]c(=O)c(CNc3ccc4oc(=O)ccc4c3)cc2c1
Structure:
Search PDB for entries with ligand similarity: